However, with the progression of obesity, prolonged and excessive increase of A-FABP may exacerbate metabolic and cardiovascular disorders through its effects on non-adipose tissues, including macrophages, endothelium, cardiomyocytes and hepatocytes. The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.